Abstract
Diseases caused by the normally pathogenic fungi are common. The vast majority of patients will not require treatment. Amphotericin B remains the gold standard when treatment is needed. The availability of ketoconazole has provided an alternative mode of therapy, but its exact place is yot yet defined.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 250-253 |
| Number of pages | 4 |
| Journal | American Review of Respiratory Disease |
| Volume | 127 |
| Issue number | 2 |
| State | Published - 1983 |
| Externally published | Yes |